US 10981934
Fused heterocyclic compound
granted A61KA61K31/444A61K31/4985
Quick answer
US patent 10981934 (Fused heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/444, A61K31/4985, A61K31/5025, A61K31/519